Seung-Woo Lee
Director/Miembro de la Junta en BENO TNR, INC. .
Origen de la red de primer grado Seung-Woo Lee.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Packaged Software | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Seung-Woo Lee a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| KOREA ROBOT MANUFACTURING CO.,LTD. | Semiconductors | Chief Executive Officer Director of Finance/CFO Comptroller/Controller/Auditor | |
| Seoul National University | College/University | Graduate Degree Undergraduate Degree | |
| WESTRISE CO., LTD. | Specialty Stores | Chief Executive Officer Comptroller/Controller/Auditor | |
| SMEC CO.,LTD | Specialty Telecommunications | Director/Board Member | |
| SONID INC. | Electronic Equipment/Instruments | Chief Executive Officer | |
| Exax Nfc Co. Ltd. | Director/Board Member | ||
| Benobio Co., Ltd. | Chief Executive Officer | ||
Ramikus Co. Ltd.
 Ramikus Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Park Hyung-Joon, Ramikus Co., Ltd. is a South Korean company that provides professional, scientific, and technical services. The company is based in Seoul, South Korea. The CEO of the company is Jib-Hoon Jung. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Korea University | College/University | Graduate Degree | |
| Yonsei University | College/University | Undergraduate Degree | |
J&J Investment Co., Ltd.
 J&J Investment Co., Ltd. Miscellaneous Commercial ServicesCommercial Services J&J Investment Co. Ltd. provides management consulting services. The company was founded on April 2, 2002 and is headquartered in Pohang-si, South Korea. | Miscellaneous Commercial Services | Chief Executive Officer | |
| FUTURECORE CO.,LTD. | Semiconductors | Director/Board Member | |
Nano Pharmasolutions, Inc.
 Nano Pharmasolutions, Inc. Pharmaceuticals: MajorHealth Technology Nano Pharmasolutions, Inc. is a pharmaceutical company based in an undisclosed location. Nano Pharmasolutions is developing a dry powder for inhalation (DPI) formulation of remedesivir to fight COVID-19. The American company's platform is based on physical vapor deposition (PVD) technology, which allows them to make drug nanoparticles with no excipients or solvents. These nanodrug particles can be used in various forms such as pills, nasal sprays, creams/salves, inhalers, and eye drops. The private company's nanotransformer™ technology can create an e-8 torr vacuum, and it uses carrier solids selected from hydrophilic pharmaceutical excipients to deposit vapor phase drugs as nanoparticles on fast-moving carriers. The company was founded by Kay Olmstead, Saeyeon Lee, Seok-Keun Koh, and Kay Olmstead has been the CEO since incorporation. | Pharmaceuticals: Major | Founder |
Estadísticas
Internacional
| Corea del Sur | 13 |
| Estados Unidos | 2 |
Sectorial
| Electronic Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 3 |
| Retail Trade | 2 |
| Communications | 2 |
Operativa
| Director/Board Member | 14 |
| Chief Executive Officer | 9 |
| Independent Dir/Board Member | 4 |
| Comptroller/Controller/Auditor | 3 |
| Graduate Degree | 2 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jib-Hoon Jung | 9 |
| Sung-Soo Kim | 4 |
| Chang-Hyun Kim | 4 |
| Jae-Jun Dong | 3 |
| Kyu-Young Lee | 2 |
| Kay Olmstead | 2 |
| Aldrin R Denny | 1 |
- Bolsa de valores
- Insiders
- Seung-Woo Lee
- Conexiones Empresas
